SWA
RPRX icon

SOA Wealth Advisors’s Royalty Pharma RPRX Stock Holding History

SOA Wealth Advisors’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.98K Buy
+9,981
New +$520K ﹤0.01% 614

Other funds holding RPRX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
KMC
Kirr Marbach & Co Columbus, Indiana $594M AUM 34% 1-Year Est. Return
SMDAM
Sumitomo Mitsui DS Asset Management Tokyo, Japan $14.5B AUM 37.68% 1-Year Est. Return
TPM
Triasima Portfolio Management Montreal, Quebec, Canada $740M AUM 69.74% 1-Year Est. Return

SOA Wealth Advisors's RPRX Position: Q2 2026 in Review

SOA Wealth Advisors opened a new position in Royalty Pharma (RPRX) in Q2 2026: 9,981 shares worth $9.98K. The stake represents ﹤0.01% of the portfolio and ranks #614 among its holdings.

75 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • SOA Wealth Advisors held 9,981 shares of Royalty Pharma worth $9.98K as of Q2 2026.
  • Royalty Pharma was a new SOA Wealth Advisors position in Q2 2026.
  • Royalty Pharma made up ﹤0.01% of SOA Wealth Advisors's portfolio in Q2 2026, its #614 holding.
  • 75 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on SOA Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.